Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.

MLA

Cracolici, Vincent, et al. “Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.” Head & Neck Pathology, vol. 12, no. 4, Dec. 2018, pp. 522–28. EBSCOhost, https://doi.org/10.1007/s12105-018-0905-7.

APA

Cracolici, V., Krausz, T., & Cipriani, N. A. (2018). Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP. Head & Neck Pathology, 12(4), 522–528. https://doi.org/10.1007/s12105-018-0905-7

Chicago

Cracolici, Vincent, Thomas Krausz, and Nicole A. Cipriani. 2018. “Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.” Head & Neck Pathology 12 (4): 522–28. doi:10.1007/s12105-018-0905-7.